The CATALIS Quebec Clinical Trials initiative has announced new public partners and industry funding as it moves closer to its goal of doubling private sector investment in the province’s early stage clinical trials (ESCT) and providing patients early access to innovative healthcare.
Organization: Montreal Neurological Institute
Canadian funding for the Toronto-based Structural Genomics Consortium (SGC) has been renewed, injecting $33 million into the ground breaking open innovation organization that determines the three-dimensional structure of proteins related to human diseases. The fourth phase of the public-private SGC will see an expansion its collaborative network to include disease and patient foundations while partnering with clinicians and research hospitals to validate new targets for drug discovery by testing its chemical probes on patients.
The National Research Council is embarking on a re-alignment of its core strengths by reaching out to academia and other players in the federal innovation system (see lead article). NEOMED is making major strides retaining critical pharmaceutical talent in the Montreal region and its actively considering a third site for its potent combination of research expertise and business collaboration
Compute Canada (CC) and the National Research Council’s astronomy and astrophysics facilities have teamed up to give astronomers greater computational power needed to process and analyze data from powerful telescopes around the globe.
Somomax Technologies Inc and École de Technologie Supérieure (ETS) have established an Industrial Research Chair to develop new in-ear auditory technologies. Montreal-based Somomax will provide $750,000 over five years and the chair will be held by Dr Jeremy Voix, former research director at Somomax. In addition to giving Somomax access to highly-skilled graduates and ETS’…